Your Article Summary
Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut
Clinical Infectious Diseases, 06/12/09
Van Vliet MJ et al. - In a study to analyze the effect of chemotherapy treatment and antimicrobial prophylaxis on intestinal bacterial populations (microbiota) among pediatric pts with acute myeloid leukemia (AML) who are prone to intestinal mucositis and infections, it appears that these pts with AML are unable to maintain colonization resistance because of a decrease in anaerobic bacteria and an increase in potentially pathogenic aerobic enterococci. This disturbance in the balance between anaerobic and aerobic bacteria will further increase the risk of gram-positive aerobic infections among immunocompromised pts with cancer.
Methods- During 36 chemotherapy cycles, fecal samples were collected from pediatric pts with AML.
- Fecal bacterial populations were analyzed by polymerase chain reaction denaturing gradient gel electrophoresis fingerprinting.
- Fluorescent in situ hybridization (FISH) analysis with specific bacterial oligonucleotide probes was used to quantify fecal bacteria.
- During chemotherapy treatment, the total number of bacteria in fecal samples was 10-9 per gram of dry weight feces, which was 100?fold lower than that in healthy control samples.
- FISH analysis showed that this decrease was the result of an up to 10,000-fold decrease in anaerobic bacteria, partly compensated for by a 100-fold increase in potentially pathogenic enterococci.
- Additional experiments showed that both prophylactic and therapeutic use of antibiotics could not sufficiently explain the tremendous changes in intestinal microbial composition.
- In vitro tests showed a direct bacteriostatic effect of chemotherapeutics.
Related Articles
Daunorubicin Versus Mitoxantrone Versus Idarubicin as Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
Journal of Clinical Oncology, 10/23/09
Relevance Score: 69%
Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response, a study of the GIMEMA CML WP
Blood, 10/09/09
Relevance Score: 69%
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome
Blood, 10/02/09
Relevance Score: 69%
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives
Current Opinion in Oncology, 10/14/09
Relevance Score: 68%
FLT3 inhibition as a targeted therapy for acute myeloid leukemia
Current Opinion in Oncology, 10/14/09
Relevance Score: 68%
Today in GI Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral ondansetron for reducing vomiting secondary to acute gastroenteritis in children – a double-blind randomized study
Alimentary Pharmacology and Therapeutics, 12/04/09
A systematic review of serologic tests in the diagnosis of necrotizing enterocolitis
Journal of Pediatric Surgery, 12/04/09
The epidemiology of hospitalization with diarrhea in rural Kenya: the utility of existing health facility data in developing countries
International Journal of Infectious Diseases, 12/04/09
Today in Peds Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
Rectal Fecal Impaction Treatment in Childhood Constipation: Enemas Versus High Doses Oral PEG
Pediatrics, 12/04/09
Invasive cholangiocarcinoma identified in congenital biliary dilatation in a 3-year-old boy
Journal of Pediatric Surgery, 12/04/09
Universal Mass Vaccination Against Rotavirus Gastroenteritis: Impact on Hospitalization Rates in Austrian Children
The Pediatric Infectious Disease Journal, 12/04/09

See Latest Articles